Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L30 pseudogene 14 (RPL30P14) is a non-coding pseudogene located in the human genome, derived from the parental ribosomal protein L30 gene (RPL30)[2][5]. Pseudogenes are genetic elements that resemble functional genes but typically have lost their protein-coding ability due to accumulated mutations or truncations and are not expressed as functional proteins[4]. There is no evidence that RPL30P14 produces a functional protein, nor is it classified as a receptor, enzyme, transporter, or other drug discovery target. The parental RPL30 gene encodes a cytoplasmic ribosomal protein that is a component of the large 60S subunit and is involved in protein synthesis, but this function does not apply to RPL30P14[1][3]. RPL30P14 is a pseudogene, not a functional gene or pharmacological target. It has no established role in disease, biology, or as a drug target. If you are searching for a molecule to target for therapeutic intervention, RPL30P14 is not appropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L30 pseudogene 14 (RPL30P14).